Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

An 82-year-old woman's hair turned white suddenly, likely due to a rare form of alopecia that targets pigmented hair.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Minoxidil 5% solution significantly improved hair density in a girl with loose anagen hair syndrome over 28 months, with no side effects.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Polarized dermoscopy is slightly better than nonpolarized for diagnosing hair disorders, with each method having its own strengths.

Some babies are born with alopecia areata, and a treatment with clobetasol propionate can regrow hair in half of the cases.

A girl with no hair neglect developed plica neuropathica in the hospital, lost all her hair, but it grew back.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Hair disorders need a holistic approach, including medical, cosmetic, and psychological support.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Machine learning can accurately identify Alopecia Areata, aiding in early detection and treatment of this hair loss condition.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.